• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Simon J Stanworth, Claire Dyer, +8 authors Michael F Murphy
  • Medicine
  • Transfusion medicine reviews
  • 2010 (First Publication: 1 July 2010)
  • Although considerable advances have been made in many aspects of platelet transfusion therapy in the last 30 years, some areas continue to provoke debate, including the use of prophylactic plateletContinue Reading
  • Simon J Stanworth, Lise J. Estcourt, +9 authors Michael F Murphy
  • Medicine
  • 2012 (First Publication: 16 November 2012)
  • Abstract 1 [][1] Background The effectiveness of prophylactic platelets (plts) to prevent bleeding in patients with hematological malignancies remains unclear. The aim of this trial was to test theContinue Reading
  • Vipul Jairath, Brennan C Kahan, +22 authors Michael F Murphy
  • Medicine
  • Transfusion medicine reviews
  • 2013 (First Publication: 1 July 2013)
  • Acute upper gastrointestinal bleeding (AUGIB) is the commonest reason for hospitalization with hemorrhage in the UK and the leading indication for transfusion of red blood cells (RBCs). ObservationalContinue Reading
  • Simon J Stanworth, Claire Dyer, Angela C. Casbard, Michael F Murphy
  • Medicine
  • Vox sanguinis
  • 2006 (First Publication: 1 July 2006)
  • BACKGROUND AND OBJECTIVES The aim of this study was to evaluate the collection of daily prospective information about bleeding outcomes in patients with thrombocytopenia, including informationContinue Reading
  • Claire Dyer, Caroline Raasch Alquist, +14 authors S J Stanworth
  • Medicine
  • Vox sanguinis
  • 2018 (First Publication: 10 January 2018)
  • BACKGROUND There continues to be uncertainty about the optimal approach to documenting bleeding data in platelet transfusion trials, with a desire to apply a common assessment tool across all trials.Continue Reading